Schedule of Unaudited Pro-Forma Results of Operations (Details) - Kenkoderm Acquisition [Member] - USD ($) $ / shares in Units, $ in Thousands |
3 Months Ended | |
|---|---|---|
Mar. 31, 2024 |
Mar. 31, 2023 |
|
| Business Acquisition [Line Items] | ||
| Revenues, net | $ 1,266 | $ 1,140 |
| Net loss allocable to common shareholders | $ (871) | $ (717) |
| Net loss per share - basic | $ (0.15) | $ (0.13) |
| Net loss per share - diluted | $ (0.15) | $ (0.13) |
| Weighted average number of shares outstanding - basic | 5,982,062 | 5,586,326 |
| Weighted average number of shares outstanding - diluted | 5,982,062 | 5,586,326 |
| X | ||||||||||
- Definition Business acquisition pro forma weighted average number of shares outstanding basic. No definition available.
|
| X | ||||||||||
- Definition Business acquisition pro forma weighted average number of shares outstanding diluted. No definition available.
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The pro forma basic net income per share for a period as if the business combination or combinations had been completed at the beginning of a period. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The pro forma diluted net income per share for a period as if the business combination or combinations had been completed at the beginning of a period. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The pro forma net Income or Loss for the period as if the business combination or combinations had been completed at the beginning of a period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The pro forma revenue for a period as if the business combination or combinations had been completed at the beginning of the period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|